Aurora Cannabis Inc. Stock Deutsche Boerse AG

Equities

21P

CA05156X8504

Pharmaceuticals

Real-time Estimate Tradegate 14:35:46 2024-05-17 EDT 5-day change 1st Jan Change
6.633 EUR -5.31% Intraday chart for Aurora Cannabis Inc. +11.78% +50.24%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 272M 200M 184M Sales 2025 * 320M 235M 216M Capitalization 564M 414M 381M
Net income 2024 * -61M -44.78M -41.19M Net income 2025 * -7M -5.14M -4.73M EV / Sales 2024 * 2.07 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 1.76 x
P/E ratio 2024 *
-6.6 x
P/E ratio 2025 *
-63.6 x
Employees 1,130
Yield 2024 *
-
Yield 2025 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
US Government Reclassifies Marijuana to Less-Restrictive Category MT
Justice Department Set to Post Cannabis Reclassification Plans MT
Aurora Cannabis Inc. Appoints Rajesh Uttamchandani to its Board of Directors CI
Aurora Cannabis Brief: Up 0.3% In US Premarket As Marks First Shipment of Medical Cannabis to the New Zealand Market MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup DJ
TSX Down More Than 1% Today and More Than 2% For April, Having Hit Record Highs Earlier In the Month; But Cannabis Stocks Hit a High MT
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading MT
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug MT
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug MT
DEA to Move to Reclassify Marijuana, Associated Press Reports MT
Aurora Cannabis Up 0.15% In US Premarket As Expands Offerings in Australia with New Range of Premium Dried Flower Products MT
Aurora Cannabis Brief: Expanding Offerings in Australia with New Range of Premium Dried Flower Products MT
Aurora Cannabis Inc. in Conjunction with MedReleaf Australia, Announce Expansion of its Portfolio with Introduction of New Range of Premium Dried Cannabis Flower Products CI
Cannabis Stocks Rise Pre-Bell After Florida Supreme Court Allows Ballot Initiative to Legalize Marijuana MT
Pot producers climb as recreational cannabis to go on Florida ballot RE
More news
1 day-5.31%
1 week+11.78%
Current month-22.43%
1 month+22.53%
3 months+91.14%
6 months+61.20%
Current year+50.24%
More quotes
1 week
6.06
Extreme 6.055
7.40
1 month
5.30
Extreme 5.3
8.63
Current year
0.34
Extreme 0.3375
8.63
1 year
0.34
Extreme 0.3375
10.79
3 years
0.34
Extreme 0.3375
86.91
5 years
0.34
Extreme 0.3375
945.60
10 years
0.34
Extreme 0.3375
1 324.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 20-07-05
Director of Finance/CFO 52 02-20
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 67 18-07-24
Director/Board Member 60 16-05-19
Director/Board Member 52 15-08-09
More insiders
Date Price Change Volume
24-05-17 6.69 -4.50% 14 312
24-05-16 7.005 +6.70% 117,856
24-05-15 6.565 +1.70% 20,392
24-05-14 6.455 +4.03% 20,285
24-05-13 6.205 +3.68% 14,555

Delayed Quote Deutsche Boerse AG, May 17, 2024 at 02:19 pm

More quotes
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
10.34 CAD
Average target price
9.681 CAD
Spread / Average Target
-6.37%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW